Fig. 2: IDCs under investigation.
MMAE monomethyl auristatin E, dHBD heterocycle-fused benzodiazepine dimer, F-HPA auristatin F-HPA, MMAF monomethyl auristatin phenylalanine, NA non available.
Fig. 2: IDCs under investigation. | npj Precision Oncology
